CFTR and cystic fibrosis: The donors are distinguished by a variety of characteristics including whether they are on inhaled, oral, or IV antibiotics (and what kind they are on), whether they had been receiving CFTR potentiator therapy or not, which CF pathogens they had cultured at the time of the sample collection and which pathogens were repeatedly detected during the preceding 2 years (Table 1).